about
PET imaging detection of macrophages with a formyl peptide receptor antagonistAtherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow.Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase.Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.Apolipoprotein E knockout mice have accentuated malnutrition with mucosal disruption and blunted insulin-like growth factor I responses to refeeding.New quantitative trait loci for carotid atherosclerosis identified in an intercross derived from apolipoprotein E-deficient mouse strains.Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.Characterization of Bglu3, a mouse fasting glucose locus, and identification of Apcs as an underlying candidate gene.Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expressionHyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.Identification of Soat1 as a quantitative trait locus gene on mouse chromosome 1 contributing to hyperlipidemiaAntiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasiaEffect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility.Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.Genes within the MHC region have a dramatic influence on radiation-enhanced atherosclerosis in miceCirculating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility.Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.Quantitative trait locus analysis of neointimal formation in an intercross between C57BL/6 and C3H/HeJ apolipoprotein E-deficient mice.Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene.Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility.siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migration.Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.Genetic linkage of hyperglycemia, body weight and serum amyloid-P in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice.Quantitative trait locus analysis of circulating adhesion molecules in hyperlipidemic apolipoprotein E-deficient mice.Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice.Association of a Vcam1 mutation with atherosclerosis susceptibility in diet-induced models of atherosclerosis.Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain.Effect of aging on fatty streak formation in a diet-induced mouse model of atherosclerosis.Direct evidence for a crucial role of the arterial wall in control of atherosclerosis susceptibility.Quantitative trait locus analysis of carotid atherosclerosis in an intercross between C57BL/6 and C3H apolipoprotein E-deficient mice.Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data.Differential responses of pulmonary arteries and veins to histamine and 5-HT in lung explants of guinea-pigs.Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.Increased reactivity to endothelin of pulmonary arteries in long-term post-obstructive pulmonary vasculopathy in rats.
P50
Q30301085-99BBA06E-642C-4509-8370-73B0A76AB76EQ30309213-AF962B41-7318-44CE-A3E6-B4C91084D3DDQ30309271-C0818D67-6A4D-4A21-A5E4-06B605C38A8EQ30311129-327E5FE0-A3AE-4381-AC51-07CCE24705FEQ30410797-9FEBA803-40F1-4910-AEDD-0CD5EC5D2FDFQ30413841-A00ECEC6-DF1A-402F-A81F-C9724049AB67Q30421525-05226AD9-7387-4F05-94AA-E16067833C98Q30421914-E2F200F0-3626-4C80-A979-D3440C5926BDQ30425082-6C7B622D-D448-4E57-8229-2B559127A364Q30428421-BF4E6A7C-2C41-4CFF-A39C-492DF1638307Q30430221-BAC8081F-6DE1-4063-BAF6-BD7CC3FF6B0BQ30430542-7CDEE6CF-5115-48A3-8683-008AAE449824Q30433172-D98D07F5-AE87-4E88-B5AF-6745C48D5095Q30433384-B0B47B9C-6AD7-47C3-8E95-A412E8B86C62Q30434230-CE3AC479-E8DF-4815-AD68-1AD5A179C0A1Q30434443-71F23105-202F-4F4C-98B2-E230A825C4ADQ30436171-D9DACD7E-916E-46C5-A606-371C75AFDE3AQ30436204-630B5BFD-7B50-448D-9A17-C3BFF6DA863BQ30438881-A7FBBDEF-E702-4426-B7F0-C75D675C60C5Q30439110-B904C3EC-1092-4D77-9BE7-4C0EBA2433F0Q30439207-5DACCAA6-2FEB-4804-97D9-5673459DB18EQ30439506-836BFBA4-FC2E-42FB-923E-BA13CDA7CFAAQ30439712-5E292352-0F78-40A3-A243-DD3B976B9EFDQ30440146-8587F43B-47F6-42A6-8E35-FB8919B9C4E0Q30440350-0A8C5B5F-A2C6-4865-9E4C-1A8330CCBB6BQ30440502-C78967D2-B6EB-4B4C-AB40-B31AEC1848BDQ30440513-27D6C1CD-41CA-4C00-92E2-407599B7DA6DQ30441329-F427750B-CA77-4645-8384-5D7FA4E6A4CEQ30441825-16B41CC6-2199-43AC-839A-8D5C1DB61D7AQ30442118-509DCF46-3308-446F-AD7E-299559264FCBQ30443593-811BE80A-7AE9-40F1-82AB-D870F9B1FE4DQ31119283-2D132052-8E93-4124-A06D-09B9B67F0A98Q43182285-338F265D-59C8-4E60-AA58-A028A8501B14Q46492183-53A9E1C3-0740-4400-B1EF-9656FCEBF7DFQ54107377-A3B24053-287C-46A4-9938-010146B9A967
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Weibin Shi
@ast
Weibin Shi
@en
Weibin Shi
@es
Weibin Shi
@nl
type
label
Weibin Shi
@ast
Weibin Shi
@en
Weibin Shi
@es
Weibin Shi
@nl
prefLabel
Weibin Shi
@ast
Weibin Shi
@en
Weibin Shi
@es
Weibin Shi
@nl
P106
P1153
7402664290
P31
P496
0000-0002-9155-613X